Literature DB >> 4065102

Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.

P H Rabbitts, J V Watson, A Lamond, A Forster, M A Stinson, G Evan, W Fischer, E Atherton, R Sheppard, T H Rabbitts.   

Abstract

The presence and synthesis of c-myc protein and mRNA in the cell cycle has been studied. We find that c-myc mRNA is present, at equivalent levels, at all times in the cell cycle with the possible exception of mitosis. Furthermore, we demonstrate that this mRNA is transcribed in both G1 and G2 phases. An analysis of the c-myc protein in vivo shows that de novo synthesis occurs in G1 and G2 and the protein turns over with a half-life of approximately 20-30 min in both phases. Furthermore, the level of c-myc protein rapidly increases in cell populations when they re-initiate the cell cycle, thereafter decreasing as the culture reaches quiescence. The results therefore suggest that expression of c-myc can be rapidly modulated and that it is activated during the G0 to G1 transition, but is expressed thereafter in the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4065102      PMCID: PMC554455          DOI: 10.1002/j.1460-2075.1985.tb03885.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  24 in total

1.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

2.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Enzyme kinetic studies in cell populations using fluorogenic substrates and flow cytometric techniques.

Authors:  J V Watson
Journal:  Cytometry       Date:  1980-09

5.  Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene.

Authors:  P H Hamlyn; T H Rabbitts
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

6.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

7.  Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations.

Authors:  A Bernheim; R Berger; G Lenoir
Journal:  Cancer Genet Cytogenet       Date:  1981-06

8.  Dual laser beam focussing for flow cytometry through a single crossed cylindrical lens pair.

Authors:  J V Watson
Journal:  Cytometry       Date:  1981-07

9.  Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.

Authors:  K B Marcu; L J Harris; L W Stanton; J Erikson; R Watt; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells.

Authors:  S R Hann; C B Thompson; R N Eisenman
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

View more
  76 in total

1.  Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses.

Authors:  Kristiina Joensuu; Jaana Hagström; Marjut Leidenius; Caj Haglund; Leif C Andersson; Hannu Sariola; Päivi Heikkilä
Journal:  Virchows Arch       Date:  2011-06-03       Impact factor: 4.064

Review 2.  DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors.

Authors:  P D'Orléans-Juste; M G Sirois; E R Edelman; D Regoli; L H Pheng; G Bkaily; C J Lindsey
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

3.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

Review 4.  The role of T cell receptor signaling thresholds in guiding T cell fate decisions.

Authors:  Julie Zikherman; Byron Au-Yeung
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

Review 5.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

6.  The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.

Authors:  D A Albert
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 7.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

8.  Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.

Authors:  Lijie Gong; Yingjie Xia; Zhenyuan Qian; Ji Shi; Jungang Luo; Guangyuan Song; Ji Xu; Zaiyuan Ye
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

9.  The human cut homeodomain protein represses transcription from the c-myc promoter.

Authors:  D Dufort; A Nepveu
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Comparative analysis of the intracellular localization of c-Myc, c-Fos, and replicative proteins during cell cycle progression.

Authors:  S Vriz; J M Lemaitre; M Leibovici; N Thierry; M Méchali
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.